Yan Chen
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Immunology top 2%
Papers in
-
- Epigenetics and DNA Methylation 29
- Ubiquitin and proteasome pathways 24
- RNA modifications and cancer 24
-
- Cancer-related molecular mechanisms research 38
- Cancer, Hypoxia, and Metabolism 28
- MicroRNA in disease regulation 15
- Co-authors
- Jin Ye (2 shared papers)Hua Huang (2 shared papers)Weibo Luo (12 shared papers)David M. Owen (1 shared paper)Weiping Li (1 shared paper)Michael Gale (1 shared paper)Fang Sun (1 shared paper)Roland Tacke (1 shared paper)
- Journals
- Frontiers in Oncology (8 papers)Frontiers in Immunology (7 papers)Biochemical and Biophysical Research Communications (6 papers)Cancer Research (6 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yan Chen
352 papers receiving 8.9k citations
Yan Chen's Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 1.8k
- Immunology 1.4k
- Molecular Biology 4.6k
- Hepatology 429
- Oncology 1.1k
Countries citing papers authored by Yan Chen
This map shows the geographic impact of Yan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Chen more than expected).
Fields of papers citing papers by Yan Chen
This network shows the impact of papers produced by Yan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Chen. The network helps show where Yan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 362 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 429 | |
| 2 | 2012 | 277 | |
| 3 | 2012 | 267 | |
| 4 | 2014 | 209 | |
| 5 | 2017 | 206 | |
| 6 | Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing Hit paper breakdown → | 2023 | 175 |
| 7 | 2014 | 174 | |
| 8 | 1997 | 170 | |
| 9 | 2015 | 156 | |
| 10 | 2020 | 137 | |
| 11 | 2018 | 128 | |
| 12 | 2006 | 112 | |
| 13 | 2022 | 111 | |
| 14 | 2019 | 111 | |
| 15 | 2011 | 108 | |
| 16 | 2017 | 107 | |
| 17 | Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB. | 2000 | 107 |
| 18 | 2020 | 100 | |
| 19 | 1992 | 99 | |
| 20 | 2018 | 99 |
About Yan Chen
Yan Chen is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Epidemiology, having authored 362 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (38 papers), Epigenetics and DNA Methylation (29 papers), Cancer, Hypoxia, and Metabolism (28 papers), Ubiquitin and proteasome pathways (24 papers), RNA modifications and cancer (24 papers), Immune Cell Function and Interaction (22 papers), interferon and immune responses (16 papers) and MicroRNA in disease regulation (15 papers). The work is most often cited by research in Cancer Research (1.8k citations), Immunology (1.4k citations), Molecular Biology (4.6k citations), Hepatology (429 citations) and Oncology (1.1k citations). Yan Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jin Ye, Hua Huang, Weibo Luo, David M. Owen, Weiping Li, Michael Gale, Fang Sun, Roland Tacke, James L. Manley and Lei Bao. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Biochemical and Biophysical Research Communications, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.